Macrophage-derived CCL1 targets CCR8 receptor in hepatic stellate cells to promote liver fibrosis through JAk/STAT pathway

[Display omitted] Liver fibrosis is caused by liver injury resulting from the wound healing response. According to recent research, the primary factor responsible for liver fibrosis is the activation of hepatic stellate cells (HSCs). C-C motif chemokine ligand 1 (CCL1) is one of several chemokine ge...

Full description

Saved in:
Bibliographic Details
Published inBiochemical pharmacology Vol. 237; p. 116884
Main Authors Diao, Shaoxi, Li, Liangyun, Zhang, Jintong, Ji, Minglu, Sun, Lijiao, Shen, Wenwen, Wu, Shuai, Chen, Zixiang, Huang, Cheng, Li, Jun
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.07.2025
Subjects
Online AccessGet full text
ISSN0006-2952
1873-2968
1873-2968
DOI10.1016/j.bcp.2025.116884

Cover

More Information
Summary:[Display omitted] Liver fibrosis is caused by liver injury resulting from the wound healing response. According to recent research, the primary factor responsible for liver fibrosis is the activation of hepatic stellate cells (HSCs). C-C motif chemokine ligand 1 (CCL1) is one of several chemokine genes clustered on chromosome 17, which is involved in immune regulation and inflammatory processes. However, the role of CCL1 in liver fibrosis has not been reported. We found that CCL1 secreted by macrophages can target and activate the receptor protein C-C motif chemokine receptor 8 (CCR8) of HSCs, accelerating liver fibrosis progression by activating the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signalling pathway. This suggested that the CCL1-mediated regulation of CCR8 is an important event in liver fibrosis progression. In conclusion, this study identified a novel signalling axis, the CCL1/CCR8/JAK/STAT pathway, which regulates the activation and apoptosis of HSCs, thus providing a novel therapeutic strategy for liver fibrosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-2952
1873-2968
1873-2968
DOI:10.1016/j.bcp.2025.116884